Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Logo MUG-Forschungsportal

Gewählte Publikation:

SHR Neuro Krebs Kardio Lipid Stoffw Microb

Schadendorf, D; Ugurel, S; Schuler-Thurner, B; Nestle, FO; Enk, A; Brocker, EB; Grabbe, S; Rittgen, W; Edler, L; Sucker, A; Zimpfer-Rechner, C; Berger, T; Kamarashev, J; Burg, G; Jonuleit, H; Tuttenberg, A; Becker, JC; Keikavoussi, P; Kampgen, E; Schuler, G.
Dacarbazine (DTIC) versus vaccination with autologous peptide-pulsed dendritic cells (DC) in first-line treatment of patients with metastatic melanoma: a randomized phase III trial of the DC study group of the DeCOG.
Ann Oncol. 2006; 17(4):563-570 Doi: 10.1093/annonc/mdj138 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Co-Autor*innen der Med Uni Graz
Becker Jürgen Christian
Ugurel-Becker Selma
Altmetrics:

Dimensions Citations:

Plum Analytics:

Scite (citation analytics):

Find related publications in this database (using NLM MeSH Indexing)
Cancer Vaccines - administration and dosage
Dacarbazine - therapeutic use
Dendritic Cells - transplantation
Humans -
Melanoma - pathology Melanoma - therapy
Neoplasm Metastasis -
Peptides - administration and dosage

Find related publications in this database (Keywords)
advanced melanoma
dentric cells
DTIC
first-line therapy
melanoma
© Med Uni Graz Impressum